|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57,500 KRW | -1.37% |
|
+1.41% | -20.14% |
| Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
| Mar. 07 | SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline | CI |
Aug 31 (Reuters) - Britain's GlaxoSmithKline and South Korea's SK Bioscience said on Tuesday the drugmakers have begun a late-stage clinical study of SK's COVID-19 vaccine candidate in combination with GSK's pandemic vaccine booster. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)
| 1st Jan change | Capi. | |
|---|---|---|
| -20.14% | 3.26B | |
| -2.86% | 87.31B | |
| +2.63% | 40.86B | |
| -21.76% | 29.36B | |
| +58.56% | 24.49B | |
| -14.78% | 17.31B | |
| -18.49% | 11.62B | |
| -15.61% | 11.31B | |
| -44.02% | 11.26B | |
| +5.17% | 8.31B |
SK BIOSCIENCE CO.,LTD. 
